https://www.selleckchem.com/pr....oducts/4-hydroxytamo
The other two individuals remain transfusion-free following HSCT. Despite a common genetic etiology, phenotypic variability was noted in this cohort. A transient response to pyridoxine was noted in two individuals but should not be considered a long-term therapeutic strategy. HSCT was curative when performed before significant iron loading occurred. Early identification of CSA and timely HSCT can result in excellent long-term outcomes. Despite a common genetic etiology, phenotypic variability was noted in thi
Like
Comment
Share
